Rare disease and orphan drug situations in Turkey and around the world
Yükleniyor...
Dosyalar
Tarih
2019
Yazarlar
Dergi Başlığı
Dergi ISSN
Cilt Başlığı
Yayıncı
Altınbaş Üniversitesi
Erişim Hakkı
info:eu-repo/semantics/openAccess
Özet
Diseases with a prevalence less than 1/2000 are defined as “Rare Diseases”. This group of diseases is a highly heterogeneous group that affects multiple systems. Approximately 80% of these are caused by genetic reasons, and the remaining 20% are caused by environmental factors or are idiopathic. Orphan drug is defined as a medicinal product designed for a life-threatening or chronically impairing rate disease but with a low possibility of obtaining a return on investment due to insufficient sales. In Turkey, where consanguineous marriage frequency is 25% on average, the probability of rare diseases is quite high. Lack of knowledge and specialist physicians, very expensive treatments, and lack of a designated regulation for rare diseases and orphan drugs are the main problems in our country. The research revealed that orphan drugs were imported to Turkey through the Turkish Pharmacists’ Association (TEB) and not covered by Social Security, therefore making it hard for the patients with low income to reach these drugs
Açıklama
Anahtar Kelimeler
Rare, Disease, Orphan, Drug
Kaynak
AURUM Journal Health Sciences
WoS Q Değeri
Scopus Q Değeri
Cilt
1
Sayı
2
Künye
Buket, A. (2019). "Rare disease and orphan drug situations in Turkey and around the world", Aurum Journal of Health Sciences, 1, 2, 95-109.
